API Makers Seek Import Curbs, GMP Upgrade Support in Budget 2026
India’s active pharmaceutical ingredient (API) manufacturers have urged the government to introduce import curbs and support for GMP upgrades in […]
BUDGET-2026
Budget 2026: Pharma Industry Eyes Duty Cuts, R&D Support and Preventive Care Boost
As the Union Budget 2026 approaches, the pharmaceutical industry is seeking policy measures focused on customs duty rationalisation, increased R&D […]
